Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients.
Open Access
- 1 September 1985
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 76 (3) , 963-969
- https://doi.org/10.1172/jci112096
Abstract
Medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCADH; EC 1.3.99.3) deficiency (MCD) is an inborn error of beta-oxidation. We measured 3H2O formed by the dehydrogenation of [2,3-3H]acyl-CoAs in a 3H-release assay. Short-chain acyl-CoA dehydrogenase (SCADH; EC 1.3.99.2), MCADH, and isovaleryl-CoA dehydrogenase (IVDH; EC 1.3.99.10) activities were assayed with 100 microM [2,3-3H]butyryl-, -octanoyl-, and -isovaleryl-CoAs, respectively, in fibroblasts cultured from normal controls and MCD patients. Without the artificial electron acceptor phenazine methosulfate (PMS), MCADH activity in fibroblast mitochondrial sonic supernatants (MS) was 54% of control in two MCD cell lines (P less than 0.05). Addition of 10 mM PMS raised control acyl-CoA dehydrogenase activities 16-fold and revealed MCADH and SCADH activities to be 5 (P less than 0.01) and 73% (P greater than 0.1) of control, respectively. Thus, the catalytic defect in MCD involves substrate binding and/or dehydrogenation by MCADH and not the subsequent reoxidation of reduced MCADH by electron acceptors. 20 microM flavin adenine dinucleotide (FAD) did not stimulate MCD MCADH activity in either the 3H-release or electron-transfer(ring) flavoprotein-linked dye-reduction assays. Mixing experiments revealed no MCADH inhibitor in MCD MS; IVDH activities were identical in both control and MCD MS. In postmortem liver MS from another MCD patient, 3H2O formation from [2,3-3H]octanoyl-CoA was 15% of control. When 3H2O formation was assayed with 200 microM [2,3-3H]acyl-CoAs, 15 mM PMS, and 20 microM FAD in fibroblast sonic supernatants from seven MCD cell lines, SCADH, MCADH, and IVDH activities were 72-112% (P greater than 0.1), 4-9% (P less than 0.01), and 86-135% (P greater than 0.1) of control, respectively, revealing no significant biochemical heterogeneity among these patients.This publication has 34 references indexed in Scilit:
- Purification of the peroxisomal fatty acyl-CoA oxidase from rat liverBiochemical and Biophysical Research Communications, 1980
- Profiles in altered metabolism. III—(Ω-1)-hydroxyacid excretion in a case of episodic hypoglycemiaJournal of Mass Spectrometry, 1980
- Demonstration of a specific mitochondrial isovaleryl-CoA dehydrogenase deficiency in fibroblasts from patients with isovaleric acidemia.Proceedings of the National Academy of Sciences, 1980
- Purification and characterization of a long-chain acyl-CoA hydrolase from rat liver microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Dicarboxylic aciduria: The response to fastingClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Acyl-CoA oxidase of rat liver: A new enzyme for fatty acid oxidationBiochemical and Biophysical Research Communications, 1978
- [50] Acyl-CoA dehydrogenases and electron-transferring flavoproteinPublished by Elsevier ,1978
- Suberylglycine excretion in the urine from a patient with dicarboxylic aciduriaClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- The purification and some properties of electron transfer flavoprotein and general fatty acyl coenzyme A dehydrogenase from pig liver mitochondria.Journal of Biological Chemistry, 1975
- The syndrome of systemic carnitine deficiencyNeurology, 1975